In Vitro Vascular Differentiation System Efficiently Produces Natural Killer Cells for Cancer Immunotherapies

Human pluripotent stem cells were differentiated into hematopoietic progenitor cells (HPCs) and Natural Killer cells using a novel organoid system. HPC engraftment potential was assessed using NSG mice.